Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Days after Japan OK, FDA Spurns Daiichi Sankyo’s Quizartinib
June 25, 2019
- Shionogi Hooks Up with Ferrer to Promote Rizmoic in Spain
June 25, 2019
- Shionogi Licenses Mulpleta, Epertinib to China’s Eddingpharm Group
June 25, 2019
- 2018 Global Pharma Market Valued at US$1.09 Trillion, Humira Resounding No. 1: IQVIA
June 24, 2019
- ViiV Supporting Campaigns to Raise HIV Diagnosis Rate in Japan: CEO
June 24, 2019
- Ex-Otsuka Kagaku Exec Becomes PeptiStar’s New President
June 24, 2019
- Lantus/Lyxumia Combo Shows Effectiveness in Japan PIII: Sanofi
June 21, 2019
- Royalty Feud with Nobel Laureate Takes Center Stage at Ono Shareholder Meeting
June 21, 2019
- Japan IBD Market Projected at 155.8 Billion Yen in 2027: Fuji Keizai
June 20, 2019
- Fujifilm to Invest 300 Million Yen in Shimane Univ. Spinoff Regenerative Medicine Biotech
June 20, 2019
- Japan Approves 1st Avastin Biosimilar
June 19, 2019
- Eisai, Harvard Researchers Develop Novel Anticancer Agent Derived from Total Synthesis of Halichondrin
June 19, 2019
- Keytruda Momentum Unabated at ASCO, Snapshot of 5 Checkpoint Inhibitors
June 18, 2019
- 281 Apply for Torii’s Voluntary Redundancy Program
June 18, 2019
- Cold Agglutinin Disease Patients Have High Thromboembolism Event Risk: Sanofi Database Study
June 18, 2019
- VC Catalys Pacific Kicks Off in Japan in Partnership with Chugai, Eisai, Takeda, and More
June 18, 2019
- Daiichi Sankyo Espha Rolls Out AstraZeneca’s 3 Cancer AGs; Gx Onslaught for Lonasen, Urief
June 14, 2019
- Sumitomo Dainippon Tweaks Healios Cell Therapy Deal, Now Leads Japan Trials
June 14, 2019
- Nesp Biosame Priced at 62.8-69.2% of Originator
June 14, 2019
- Japanese Drug Makers Beefing Up China Biz amid Regulatory Tailwind
June 14, 2019
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…